Transcription
CURRICULUM VITAEMichael J. Ross, M.D.Albert Einstein College of Medicine/Montefiore Medical CenterDivision of NephrologyUllmann 6151300 Morris Park AveBronx, NY 10461michael.ross@einstein.yu.eduEDUCATION1991 B.S.Biology, Tufts University1995 M.D. New York University School of MedicinePOSTGRADUATE TRAINING1995-1998Internship/Residency in Internal Medicine, Duke University MedicalCenter, Durham, NC1998-2001Research Fellowship in Nephrology, Mount Sinai School of MedicineNew York, NYMentor: Paul Klotman, MDResearch training supported by Fellowship Award from National KidneyFoundation of NY/NJ and NIH T32 Training GrantPROFESSIONAL EMPLOYMENT AND HOSPITAL APPOINTMENTS2001-2017Medical Staff AttendingThe Mount Sinai HospitalNew York, NY2001-2002Instructor of MedicineIcahn School of Medicine at Mount SinaiNew York, NY2003-2004Associate Program DirectorProgramNephrology Fellowship TrainingIcahn School of Medicine, New York,NY2003-2005Director, Mt. Sinai NephrologyNY, Fellows Outpatient ClinicIcahn School of Medicine, New York,2003-2010Assistant Professor of MedicineIcahn School of Medicine at Mount SinaiNew York, NY2003-2004Program DirectorNephrology Fellowship TrainingProgram, Icahn School of Medicine,New York, NY2004-2017Basic Science ResearchGraduate Training FacultySchool of Biological Sciences,Icahn School of Medicine at Mount SinaiNew York, NY2010-2017Associate Professor of Medicine Icahn School of Medicine at Mount SinaiNew York, NY
2014-2017Staff PhysicianJames J. Peters VA Medical Center,Bronx, NY2014-2017Chief, Renal SectionJames J. Peters VA Medical Center,Bronx, NY2014-2017Medical DirectorJames J. Peters VA Medical CenterDialysis Unit, Bronx, NYAlbert Einstein College of MedicineMedicine/ Montefiore Medical CenterBronx, NY2017-present Chief, Division of NephrologyBOARD CERTIFICATION1998, New York, License# 2099251998 Internal Medicine, (American Board of Internal Medicine), recertified 2010-20202000 Nephrology, (American Board of Internal Medicine), recertified 2010-2020PROFESSIONAL SOCIETY MEMBERSHIPS:Member, American Society of Nephrology, 2009-presentFellow, American Society of Nephrology, 2013-presentMember, International Society of Nephrology, 2012-presentMember, New York Society of Nephrology, Cum Laude, Tufts UniversityAssistant Chief Resident, Duke University Department of Medicine,First place, New York Society of Nephrology Fellows’ Night researchpresentationsSolomon Silver Award in Clinical Medicine, Icahn School of Medicine atMount SinaiDr. Harold and Golden Lamport Research Award, Icahn School ofMedicine at Mount SinaiOTHER PROFESSIONAL ACTIVITIES2004-2007American Heart Association Grant Review Study Section2004-2015Director, Nephrology Fellowship Training Program, Icahn School ofMedicine, New York, NY2007-presentEditorial Board, American Journal of Physiology, Renal2007-presentCo-Chair, International Network for Strategic Initiative in Global HIVTrials (INSIGHT) Renal Working Group2007-2008Co-Chair, American Society of Nephrology Training Program DirectorsCommittee on “The Match” - Committee convened to facilitate entry ofNephrology into the National Resident Matching Program. Nephrologyentered the Medical Specialties Match in 2008.2
2008Ad hoc reviewer, South African National Health Laboratory ServiceResearch Trust Grants, Medical Research Council2009-2012National Kidney Foundation - Grant Review Committee2009-2016Editorial Board, International Journal of Nephrology2009-presentNephrology Accreditation Appeals Panel Member, AccreditationCouncil for Graduate Medical Education (ACGME)2009Ad hoc reviewer, American Association for the Advancement ofScience Research Competitiveness Program2009-2012Doris Duke Clinical Research Fellowship admissions committee2010-2015American Society of Nephrology Training Program Directors ExecutiveCommittee2010-2016American Society of Nephrology Grants Review Committee2010-2014Infectious Diseases Society of America – invited committeemember, developed clinical practice guidelines on the managementof chronic kidney disease in HIV-positive patients2011-2015Chair, Americansubcommittee2011, 2013NIH/NIAD Special Emphasis Panel study section member2012-13Program Chair, New York Society of Nephrology2012-presentDeputy Editor, Kidney International [2nd highest impact factoramong nephrology research journals]2013-2014NIH/NIDDK Special Emphasis Panel study section member2013-2015American College of Physicians Medical Knowledge SelfAssessment (MKSAP17) Nephrology Writing Committee2013Ad hoc reviewer, U.S.-Israel Binational Science FoundationTransformative Science Program2013-14Secretary & Treasurer, New York Society of Nephrology2014, 2015, 2016Ad hoc reviewer, NIH NeuroAIDS and End Organ Diseases (NAED)grant study section2014-15Vice President, New York Society of Nephrology2015-16President, New York Society of Nephrology2015American Society of Nephrology – Nephrology Match Taskforce(convened by ASN Council to determine how US nephrology fellowshipprograms should respond to declining number of fellowship applicants)2015-presentChair, American Society of Nephrology Match Oversight Task Force(convened by ASN Council with charge to “Monitor the 2015Nephrology Match; identify potential match violations; report potentialviolations to NRMP; identify potential sanctions to apply in addition toNRMP’s, and sanction any confirmed 3
2016-2018Nephrology Section Editor, American College of Physicians MedicalKnowledge Self-Assessment Program (MKSAP) 18RESEARCHGrant support in past five years:Funding Source, Project Title &NumberNIH/NIDDK,R01DK112258, Impact of earlyantiretroviral therapy on kidneydisease outcomes(selected for funding, NOApending)NIH/NIDDK,R01DK108346,The role of APOL1 polymorphismsin promoting HIV-related kidneyinjuryRole inProjectCoinvestigatorDatesDirect Costs12/1/1611/30/21pending9/2015-6/2020 196,963/yrPINIH/NIDDK, R01DK101338, Novelmechanisms of antiretroviralprotection against HIV-relatedkidney diseasesPI9/15/20146/30/2019 225,000/yrNIH/NIDDK,P30DK096493 (NCE)Pilot grant, Role of the ubiquitinlike protein FAT10 incardiovascular and kidney injuryPI7/2014-6/2017(NCE) 50,000CoNIH/NIDDK, P01DK056492investigatorThepathogenesisofHIV for clinicalassociated nephropathy (Core C)core forprogramNIH/NIDDK, R01DK078510project grantThe role of FAT10 in thepathogenesis of 30/12 205,000/yrINVITED PRESENTATIONS (since 2012):1/2012“Biomarker predictors of progressive chronic kidney disease in the SMARTstudy” International Network for Strategic Initiatives in Global HIV Trials(INSIGHT) Scientific Meeting, Bethesda, MD1/2012“HIV-induced Renal Injury”, Nephrology Grand Rounds, University ofPennsylvania, Philadelphia, PA4
5/2012Co-Chair, American Society of Nephrology Highlights Meeting, New York, NY3/2013Moderator, “Controversies in Kidney Disease Symposium”, New York, NY8/2013“HIV-related kidney diseases” Department of Medicine Grand Rounds, StatenIsland University Hospital, Staten Island, NY9/2013“Initial Approach to Renal Disease”, “Hyperkalemia”, New York CityNephrology Fellows “Boot Camp”, sponsored by NY Society of Nephrology9/2013Moderator, “Controversies in Kidney Disease Symposium”, New York, NY10/2013“HIV-associated kidney diseases” Eighth Annual Congress of Nephrology inInternet9/2014“Initial Approach to Renal Disease”, New York City Nephrology Fellows “BootCamp”, sponsored by NY Society of Nephrology10/2014“HIV-related kidney diseases” Nephrology Grand Rounds, Winthrop UniversityHospital, Mineola, NY11/2014“Combination ART Nephrotoxicity in HIV: How Big a Problem?”, Invitedplenary talk, American Society of Nephrology Kidney Week, Philadelphia, PA6/2015“HIV-associated nephropathy: a 30 year perspective” Invited speaker,NIH/NIDDK-sponsored “ApoL1 and Kidney Diseases workshop”, Bethesda,MD6/2015“HIV-related kidney diseases” Nephrology Grand Rounds, MetropolitanHospital, New York, NY10/2015“Hyponatremia and Hypernatremia” Invited speaker, 10th Annual Mid-AtlanticHospital Medicine symposium, New York, NY11/2015“Kidney injury in HIV-positive patients”, Nephrology Grand Rounds, Universityof Connecticut School of Medicine. Farmington, CT.11/2015“Kidney disease in HIV patients: new spectrum in the ART-era”, Plenarysession moderator, American Society of Nephrology Kidney Week, SanDiego, CA4/2016“ASN Match Oversight Task Force Report”; 2016 American Society ofNephrology Fellowship Program Training Program Directors Annual Retreat,Chicago, IL3/2016“HIV-induced kidney injury”, Nephrology Grand Rounds, Vanderbilt University,Nashville, TN4/2016“Kidney injury syndromes in HIV-positive patients”, Medicine Grand Rounds,Metropolitan Hospital, New York, NY5/2016“Acute and chronic kidney injury in HIV positive patients”, RichmondUniversity Medical Center, Staten Island, NY9/2016“Mechanisms of HIV-induced kidney injury”, Renal grand rounds, AlbertEinstein College of Medicine”9/2016Role of APOL1 in HIV-mediated kidney injury, Innovative Research in HIV inKidney, Urology and Hematology Meeting Symposium, NIH/NIDDK,Bethesda, MD5
9/2016Role of APOL1 in HIV-mediated kidney injury, Nephrotic Syndrome StudyNetwork (NEPTUNE) Investigators Meeting, Baltimore, MD11/2016“HCV and the kidney: Let bygones be bygones”, Moderator, American Societyof Nephrology Kidney Week, Chicago, IL11/2016“Hepatitis C Virus Infection and Patients with Kidney Disease”, Moderator,American Society of Nephrology Kidney Week, Chicago, IL11/2016“ASN’s Road Map for Training: Overview of the Nephrology Match”, AnnualAmerican Society of Nephrology Division Chiefs and Training ProgramDirectors Meeting, Chicago, IL2/2017“Novel insights into HIV-induced kidney injury”, Developmental and MolecularBiology Program Research Seminar. Albert Einstein College of Medicine,Bronx, NY3/2017“Role of FAT10 in HIV-induced kidney injury”, 1st Annual FAT10 in Cancerand Immune Regulation Symposium, Weizmann Institute, Rehovot, Israel4/2017“Kidney injury in HIV-positive patients”, Department of Medicine GrandRounds, Stony Brook University Medical Center, Stony Brook, NY“American Society of Nephrology Match Oversight Task Force Report”,American Society of Nephrology Training Program Directors AnnualRetreat, Chicago, IL5/2017BIBLIOGRAPHYOriginal Communications in Reviewed Journals:Ross MJ, Bruggeman LA, Wilson PW, Klotman PE. Microcyst formation and HIV-1gene expression occur in multiple nephron segments in HIV-associated nephropathy. JAm Soc Nephrol. 12(12):2645-51. 2001.Kaufman L., Hayashi K., Ross M J, Ross MD, Klotman PE. Sidekick 1 is upregulated inHIV-associated nephropathy. J Am Soc Nephrol. 15(7). 2004.Ross MJ, Martinka S, Bruggeman LA. NF-kB regulates Fas-mediated apoptosis in HIVassociated nephropathy. J Am Soc Nephrol. 16(8):2403-11. 2005.Schwartz EJ, Szczech LA, Ross MJ, Klotman, ME, Winston JA, Klotman PE. HAARTand the Epidemic of HIV End Stage Renal Disease. J Am Soc Nephrol. 16(8):241220. 2005.Zerhouni-Layachi B, Husain M, Ross MJ, Marras D, Sunamoto M, Liu X, Klotman PE,and Klotman ME. Dual Tropism of Human Immunodeficiency Virus Type 1 (HIV-1)Envelopes Derived from Renal Tubular Epithelial Cells of Patients with Renal Diseases.AIDS. 20(4):621-4. 2006.Ross MJ, Wosnitzer M, Ross, MD, et al. Role of the ubiquitin-like protein FAT10 inepithelial apoptosis in renal disease. J Am Soc Nephrol. 17(4):996-1004. 2006.Ross MJ, Fan C, Ross MD, et al. HIV-1 infection initiates an inflammatory cascade inhuman renal tubular epithelial cells. J AIDS. 42(1):1-11. 2006.*Kaufman L, Yang G, Hayashi K, Ashby JR, Huang L, Ross, MJ, Klotman ME, KlotmanPE. The Homophilic Adhesion Molecule Sidekick-1 Contributes to Augmented Podocyte6
Aggregation in HIV-associated Nephropathy. FASEB J. May;21(7):1367-75. [PMID17307840]. 2007.*Mocroft, A., Wyatt, C., Szczech, L., Neuhaus, J., El-Sadr, W., Tracy, R., Kuller, L.,Shlipak, M., Angus, B., Klinker, H., and Ross, MJ. Interruption of antiretroviral therapyis associated with increased plasma cystatin C: Results from the SMART Study. AIDS.23, 71-82. 2009.*Snyder A, Alsauskas Z, Gong P, Rosenstiel P, Klotman M, Klotman P, Ross MJ:FAT10: a novel mediator of Vpr-induced apoptosis in HIV-associated nephropathy. JVirol. 83;11983-11988. 2009.*Gong, P., Canaan, A., Wang, B., Leventhal, S., Snyder, A., Nair, V., Cohen, C. D.,Kretzler, M., D'Agati, V., Weissman, S., and Ross, M. J. The ubiquitin-like proteinFAT10 mediates NF-kappaB activation. J Am Soc Nephrol. 21:316. 2009.Snyder A, Alsauskas ZC, Leventhal JS, Rosenstiel PE, Gong P, Chan J, Barley K, HeC, Klotman M, Ross MJ, Klotman PE. HIV-1 viral protein r induces ERK and caspase-8dependent apoptosis in renal tubular epithelial cells. AIDS, 24:1107-1119. 2010.Neuhaus, J., Jacobs, D.R., Baker, J.V., Calmy, A., Duprez, D., La Rosa, A., Kuller, L.,Pett, S.L., Ristola, M., Ross, M.J., Shlipak, M., Tracy, R., and Neaton, J.D. Markers ofInflammation, Coagulation and Renal Function Are Elevated in Adults with HIVInfection. J Infect Dis. 201:1788-1795. 2010.Mallipattu, S.K., and Ross, M.J. Methotrexate in the urine. Kidney Int. 80:226. 2011.Chen, P., Chen, B.K., Mosoian, A., Hays, T., Ross, M.J., Klotman, P.E., and Klotman,M.E. Virological Synapses Allow HIV-1 Uptake and Gene Expression in Renal TubularEpithelial Cells. J Am Soc Nephrol. 22(3): 496-507. 2011.Leventhal, J.S., Alsauskas, Z., Snyder, A., Gong, P., Wang, B., D’Agati, V., and Ross,M.J. Renal HIV Expression Is Unaffected by Serum LPS Levels in an HIV TransgenicMouse Model of LPS Induced Kidney Injury. PLoS One. 6:e20688. 2011.Papeta, N., Kiryluk, K., Patel, A., Sterken, R., Kacak, N., Snyder, H.J., Imus, P.H.,Mhatre, A.N., Lawani, A.K., Julian, B.A., Wyatt, R.J., Novak, J., Wyatt, C.M., Ross,M.J., Winston, J.A., Klotman, M.E., Cohen, D.J., Appel, G.B., D’Agati, V.D., Klotman,P.E., and Gharavi, A.G. APOL1 variants increase risk for FSGS and HIVAN but not IgAnephropathy. J Am Soc Nephrol. 22:1991-1996. 2011.Jin, Y., Ratnam, K., Chuang, P. Y., Fan, Y., Zhong, Y., Dai, Y., Mazloom, A. R., Chen,E. Y., D’Agati, V., Xiong, H., Ross, M. J., Chen, N., Ma’ayan, A., and He, J. C. Asystems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat Med.18:580-588 .2012.Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A,Lundgren J, Ross MJ*, Wyatt CM*: Hepatitis B and C Co-Infection Are IndependentPredictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults.PLoS ONE 7:e40245, (*co-senior authors). 2012.Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, MorlatP, Moranne O, Smith C, Lundgren JD: Exposure to Antiretrovirals (ARVs) and Risk ofRenal Impairment among HIV-positive Persons with Normal Baseline Renal Function:the D:A:D study. J Infect Dis 2013.7
Ganesan A, Krantz EM, Huppler Hullsiek K, Riddle MS, Weintrob AC, Lalani T, OkuliczJF, Landrum M, Agan B, Whitman TJ, Ross MJ, Crum-Cianflone NF: Determinants ofincident chronic kidney disease and progression in a cohort of HIV-infected personswith unrestricted access to health care. HIV Med 14:65-76, 2013Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, MorlatP, Moranne O, Smith C, Lundgren JD; D:A:D Study Group. Association betweenantiretroviral exposure and renal impairment among HIV-positive persons with normalbaseline renal function: the D:A:D study. J Infect Dis. 1;207(9):1359-69. 2013.Dai Y, Gu L, Yuan W, Yu Q, Ni Z, Ross MJ, Kaufman L, Xiong H, Salant DJ, He JC,Chuang PY. Podocyte-specific deletion of signal transducer and activator oftranscription 3 attenuates nephrotoxic serum-induced glomerulonephritis. Kidney Int.84:950-961. 2013.Lucas, G., Cozzi-Lepri, A., Wyatt, C., Post, F., Bormann, A., Crum-Cianflone, N., andRoss, M. Glomerular filtration rate estimated using creatinine, cystatin C or bothmarkers and the risk of clinical events in HIV-infected individuals. HIV Med 15:116-123.PubMed PMID: 24024499. 2014.Lucas, GM, Ross, MJ, Stock, PG, Shlipak, MG, Wyatt, CM, Gupta, SK, Atta, MG,Wools-Kaloustian, KK, Pham, PA, Bruggeman, LA, Lennox, JL, Ray, PE, and Kalayjian,RC. Clinical Practice Guideline for the Management of Chronic Kidney Disease inPatients Infected With HIV: 2014 Update By the HIV Medicine Association of theInfectious Diseases Society of America. Clin Infect Dis; 59(9), e96-e138. 2014.Ryom, L., Mocroft, A., Kirk, O., Ross, M., Reiss, P., Fux, C. A., Morlat, P., Moranne, O.,Smith, C., El-Sadr, W., Law, M., and Lundgren, J. D. Predictors of advanced chronickidney disease and end-stage renal disease in HIV-positive persons. AIDS 28, 187-199.2014.Kamara, D. A., Ryom, L., Ross, M., Kirk, O., Reiss, P., Morlat, P., Moranne, O., Fux, C.A., Mocroft, A., Sabin, C., Lundgren, J. D., and Smith, C. J. Development of a definitionfor Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.BMC Nephrol 15, 51. 2014.Mocroft A, Lundgren J, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D,Heuhaus J, Fux C, Moranne O, Morlat P, Johnson M, Ryom L; Data on Adverse Events(D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT studygroup. A clinically useful risk-score for chronic kidney disease in HIV infection. J IntAIDS Soc ;17(4 Suppl 3):19514. PMID: 25394023; PMCID: PMC4224906. 2014.Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D,Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group;Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRITstudy group. Development and validation of a risk score for chronic kidney disease inHIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015 Mar31;12(3):e1001809. PMID: 25826420; PMCID: PMC4380415. 2015.Achhra AC, Mocroft A, Ross MJ, Ryom L, Lucas GM, Furrer H, Neuhaus J,Somboonwit C, Kelly M, Gatell JM, Wyatt CM; International Network for StrategicInitiatives in Global HIV Trials (INSIGHT) START Study Group. Kidney disease inantiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictorsof kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral8
Treatment (START) trial. HIV Med;16 Suppl 1:55-63. PMID: 25711324; PMCID:PMC4341947. 2015.Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad,Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study.Cumulative and current exposure to potentially nephrotoxic antiretrovirals anddevelopment of chronic kidney disease in HIV-positive individuals with a normalbaseline estimated glomerular filtration rate: a prospective international cohort study.Lancet HIV. 3:e23-32. 2016.Leventhal JS, Ni J, Osmond M, Lee K, Gusella GL, Salem F, Ross MJ. AutophagyLimits Endotoxemic Acute Kidney Injury and Alters Renal Tubular Epithelial CellCytokine Expression. PLoS One. 11(3):e0150001. 2016.Ryom, L, Lundgren, JD, Ross, M, Kirk, O, Law, M, Morlat, P, Smit, C, Fontas, E, Fux,CA, Hatleberg, CI, de Wit, S, Sabin, CA, Mocroft, A, D:A:D, SG. Renal Impairment andCardiovascular Disease in HIV-positive Individuals; The D:A:D Study. J Infect Dis.PMID: 27485357. 2016.Ryom L, Mocroft A, Kirk O, Reiss P, Ross M, Smith C, Moranne O, Morlat P, Fux CA,Sabin C, Phillips A, Law M, Lundgren JD; D:A:D study group. Predictors of eGFRprogression, stabilisation or improvement after chronic renal impairment in HIV-positiveindividuals. AIDS. 2017 Mar 28. PMID: 28353536.Kent R, Gopalakrishnan VP, Menon MC, Ross MJ. The Case: Labile creatinine levels ina patient with breast cancer. Kidney Int. 2017 Mar;91(3):761-762. PMID: 28202178.Books, Chapters in Books, and Review Articles:Ross MJ, Klotman PE, Winston JA. HIV-associated nephropathy: case study andreview of the literature. AIDS Patient Care and STD’s. 14(12):637-46. 2000.Ross, MJ, Klotman PE. Recent progress in HIV-associated nephropathy. J Am SocNephrol. 13(12). 2997-3004. 2002.Ross MJ, Klotman PE. HIV-associated nephropathy. AIDS. 18(8): 1089-99. 2004.Lu TC and Ross, MJ. HIV-associated nephropathy: a brief review. Mt Sinai J Med.72(3):193-9. 2005.Ross, MJ. Gene candidates in HIV-associated nephropathy. Expert Review of ClinicalImmunology. 2(6), 839-842. 2006.Ross MJ and Klotman PE, Molecular Pathogenesis of HIV-associated Nephropathy, inMolecular and Genetic Basis of Renal Disease: A Companion Guide to Brenner andRector's The Kidney, D. Mount and M. Pollak, Editors. Elsevier: Philadelphia. 2007.Rubinstein S, Haimov M, Ross MJ. Midodrine-induced vascular ischemia in ahemodialysis patient: a case report and literature review. Ren Fail. 30:808-812. 2008.Leventhal, J.S., and Ross, M.J. Pathogenesis of HIV-Associated Nephropathy. SeminNephrol. 28:523-534. 2008.Leventhal J and Ross MJ. HIV-associated nephropathy, in Current Diagnosis andTreatment in Nephrology and Hypertension. E Lerma, Editor. 2009.Snyder A, Ross MJ. Murine models of Vpr-mediated pathogenesis. Curr HIV Res. 7,129-135. 2009.9
Kaufman L and Ross MJ. Biomarkers for HIV/AIDS, in Biomarkers of toxicity: A NewEra in Medicine, VS Vaidya and J Bonventre, Editors. John Wiley and Sons, New York,2010.Alsauskas, Z. C., Medapalli, R. K., and Ross, M. J. Expert opinion on pharmacotherapyof kidney disease in HIV-infected patients. Expert Opin Pharmacother 12, 691-704.2011.Medapalli RK and Ross, MJ. Potassium Disorders, in Handbook of Hospital Medicine,Dunn A and Kathuria N, Editors. World Scientific, New Jersey, 2012.Alsauskas Z and Ross, MJ. Sodium Disorders, in Handbook of Hospital Medicine, DunnA and Kathuria N, Editors. World Scientific, New Jersey, 2012.Leventhal, J.S., He, J.C., and Ross, M.J. Autophagy and Immune Response inKidneys. Semin Nephrol. 34(1):53-61. 2014.Ross, M. J. (2014). Advances in the pathogenesis of HIV-associated kidney diseases.Kidney Int. 86, 266-274. 2014.Coates PT, Ross M, Schlöndorff D. Kidney international web focus on transplantation.Kidney Int. 85(2):227-9. PubMed PMID: 24487359. 2014.Wolf T, Ross MJ*, and Davenport A. Minimizing risks associated with renalreplacement therapy in patients with Ebola Virus Disease. Kidney Int. 2015. 87, 5-7.2015.Del Bello D, Ross MJ*, Huprikar SS (*co-corresponding author). Hepatitis C virusinfection and kidney transplantation: newer options and a brighter future ahead? KidneyInt. 88(2):223-5. PubMed PMID: 26230200. 2015.Lin, J and Ross MJ. Acute Glomerulonephritis, in The 5-Minute Clinical Consult 2016!,Domino F, Editor. Lippincott Williams & Wilkins: Philadelphia, 2015.Hsu CY, Parker MG, Ross MJ, Schmidt RJ, Harris RC; ASN Nephrology Match TaskForce. Improving the Nephrology Match: the Path Forward. J Am Soc Nephrol.26(11):2634-9. PubMed PMID:26341128; PubMed Central PMCID: PMC4625687.2015.Ross MJ, Chronic Kidney Disease. in Medical Knowledge and Self AssessmentProgram 17, Patrick Alguire, Editor. American College of Physicians: Philadelphia,2015.Menon MC, Ross MJ. Epithelial-to-mesenchymal transition of tubular epithelial cells inrenal fibrosis: a new twist on an old tale. Kidney Int. 89(2):263-6. 2016.Lin, J and Ross MJ. Acute Glomerulonephritis, in The 5-Minute Clinical Consult 2017!,Domino F, Editor. Lippincott Williams & Wilkins: Philadelphia, 2016.Leventhal JS, Ross MJ. LAPping up dead cells to prevent lupus nephritis: a novel rolefor noncanonical autophagy in autoimmunity. Kidney Int. Aug;90(2):238-9. PubMedPMID: 27418084. 2016.Leventhal JS, Wyatt CM, Ross MJ. Recycling to discover something new: the role ofautophagy in kidney disease. Kidney Int. 2017 Jan;91(1):4-6. PMID: 28003091.Nadkarni GN, Wyatt CM, Murphy B, Ross MJ. APOL1: a case in point for replacingrace with genetics. Kidney Int. 2017 Apr;91(4):768-770. PMID: 28314574.10
Abstracts:5/2000“Tubular microcysts in HIV-associated nephropathy are similar to cysts inautosomal dominant polycystic kidney disease” Ross MJ, Bruggeman LA,Wilson PD, Klotman PE, New York Society of Nephrology Fellows Night(1st place)11/2000“Tubular microcysts in HIV-associated nephropathy (HIVAN) are similar tocysts in autosomal dominant polycystic kidney disease (ADPKD)”, RossMJ, Bruggeman LA, Wilson PD, Klotman PE, American Society ofNephrology Renal Week, Toronto, CA11/2001“HIV-1 infects multiple nephron segments in HIV-associated nephropathy”,Ross MJ, Bruggeman LA, Wilson PD, Klotman PE, American Society ofNephrology Renal Week, San Francisco, CA11/2002“HIV-Induced Differential Gene Expression in Renal Epithelial Cells from aPatient with HIV-Associated Nephropathy”, Ross MJ, Ross MD, KlotmanPE, American Society of Nephrology Renal Week, Philadelphia, PA11/2003“Identification of Diubiquitin as a Novel Candidate Gene in thePathogenesis of HIV-Associated Nephropathy”, Ross MJ, Ross MD,Klotman PE, American Society of Nephrology Renal Week, San Diego,CA11/2003“Differential Gene Expression in Human Proximal Tubular Epithelial CellsFollowing Infection by HIV-1”, Ross MJ, Ross MD, Klotman PE, AmericanSociety of Nephrology Renal Week, San Diego, CA11/2004“Diubiquitin Is Upregulated in Renal Parenchymal Cells in HIV-AssociatedNephropathy”, Ross MJ, Granelli B, Klotman PE, American Society ofNephrology Renal Week, St. Louis, MO11/2005“The proapoptotic protein FAT10 localizes to mitochondria and nuclei inrenal epithelial cells”, Wosnitzer WS, Shi Y, Klotman PE, Ross MJ,American Society of Nephrology Renal Week, Philadelphia, PA11/2005“Role of the ubiquitin-like protein FAT10 in epithelial apoptosis in renaldisease“, Ross MJ, Wosnitzer MS, Wilson PD, Klotman ME, Klotman PE,American Society of Nephrology Renal Week, Philadelphia, PA6/2006“A Role for the Ubiquitin-like Protein FAT10 in the Pathogenesis ofApoptosis in Renal Disease, Ross MJ, Wosnitzer MS, Wilson PD, KlotmanME, Klotman PE, NIH/NIDDK Young Investigators Meeting, Bethesdsa,MD11/2006“Role of the Ubiquitin-Like Protein FAT10 in Renal Epithelial Apoptosis”,Kim JY, Shi Y, Ross MJ, American Society of Nephrology Renal Week,San Diego, CA8/2007“Role of the ubiquitin-like protein FAT10 in renal disease”, "Gong P, BalijaT, Shi Y, Stern L, D'Agati V, Klotman PE, Ross MJ, NIH Ubiquitin andUbiquitin-like Modifications in Viral Infection and Immunity meeting,Bethesda, MD11
11/2007“Role of the ubiquitin-like protein FAT10 in renal disease”, Gong P, BalijaT, Shi Y, Stern L, D'Agati V, Paul E Klotman, Ross MJ, American Societyof Nephrology Renal Week, San Francisco, CA7/2008“Interruption of antiretroviral therapy is associated with an increase inplasma cystatin C: Results for a random sample of patients in theStrategies for Management of Antiretroviral Therapy (SMART) Trial”, M.Ross, A. Mocroft, for the SMART Study Group, International AIDSConference, Mexico City, Mexico11/2008“FAT10 is necessary for NFepithelial cells”, Gong P, Canaan A, Leventhal J, Snyder A, Wang B,Klotman P, Weissman S, Ross MJ, American Society of Nephrology RenalWeek, Philadelphia, PA3/2009“FAT10: a Novel Facilitator of HIV Viral Protein R-Induced Apoptosis inHIV-Associated Nephropathy”, Snyder A, Gong P, Rosenstiel P, KlotmanME, Klotman PE, Ross MJ, Conference on Retroviruses and OpportunisticInfections, Montreal, Canada11/2009LPS Does Not Result in Worse Kidney Injury or Increased HIVTranscription in an Transgenic HIV Mouse Model, " Leventhal JS, SnyderA, Alsauskas Z, Wang B, Gong P, Ross MJ, American Society ofNephrology Renal Week, San Diego, CA3/2010“HIV-1 Vpr induces ERK and caspase-8 dependent apoptosis in renaltubular epithelial cells”, Snyder A, Leventhal JS, Rosenstiel P, AlsauskasZ, Barley K, Gong P, Chan J, Klotman ME, Klotman PE, Ross MJ,Conference on Retroviruses and Opportunistic Infections, San Francisco,CA“Determinants of Incident Chronic Kidney Disease (CKD) in a Cohort ofHIV-infected Patients with Free Access to Care”, Ganesan A, Krantz E,Huppler-Hullsiek K, Ross M, Mark Riddle, Landrum M, Lalani T, WeintrobA, Agan B, Crum-Cianflone N, Conference on Retroviruses andOpportunistic Infections, San Francisco, CA“Predictors of Chronic Kidney Disease in the SMART trial”, Neuhaus J,Mocroft A, Wyatt CM, Ross MJ for the INSIGHT SMART Study Group,Conference on Retroviruses and Opportunistic Infections, Boston, MA“Lipid Particle Concentrations and Markers of Renal Disease in SMART“,Bormann A, Neuhaus J, Ross M, Duprez D for the INSIGHT SMARTStudy Group, Conference on Retroviruses and Opportunistic Infections,Boston, MA“Lack of flow in dilated renal tubules in murine model of HIV-associatednephropathy”, Omolayo O, Leventhal JS, Ross MJ, American Society ofNephrology Kidney Week, Philadelphia, PA“Baseline Creatinine-based eGFR and CC as Predictors of ClinicalEvents: SMART Study”, G Lucas, A Cozzi-Lepr A, C Wyatt, F Post, ABormann, N Crum-Cianflone, M Ross and INSIGHT SMART Study Group,Conference on Retroviruses and Opportunistic Infections, Seattle, WA“Do inflammatory and coagulation biomarkers predict progression ofchronic kidney disease in SMART and ESPRIT?” Neuhaus J, Mocroft A,Wentworth D, Estébanez M, Knysz B, Rubio R, Ross M and the INSIGHT3/20103/20113/201111/20112/20122/201212
1411/201411/20143/20153/2015Study Group, Conference on Retroviruses and Opportunistic Infections,Seattle, WA“Limou S, Johnson R, Neaton J, Neuhaus J, Ross M, Winkler C, Kopp J,and INSIGHT SMART Study Group”, Conference on Retroviruses andOpportunistic Infections, Seattle, WA“Exposure to antiretrovirals (ARVs) and the risk of renal impairmentamong HIV persons with normal baseline renal function: the D:A:Dstudy”, L Ryom, A Mocroft, SW Worm, DA Kamara, P Reiss, M Ross, CFux, P Morlat, O Moranne, C Smith, O Kirk, JD Lundgren, Conferenceon Retroviruses and Opportunistic Infections, Seattle, WA“FAT10 Knockout Mice are Protected from HIV Associated Nephropathy”,Ross MJ, Wang B, Gong P, American Society of Nephrology KidneyWeek, San Diego, CA“The ubiquitinlike protein FAT10 inhibits autophagy in renal tubularepithelial cells”, Ross MJ, Wang B, Leventhal JS, Gong P, Ame
Michael J. Ross, M.D. Albert Einstein College of Medicine/Montefiore Medical Center . 1991 B.S. Biology, Tufts University 1995 M.D. New York University School of Medicine POSTGRADUATE TRAINING 1995-1998 Internship/Residency in Internal Medicine, Duke University Medical . 2009-2012 Doris Duke Clinical Research Fellowship admissions committee
